248 related articles for article (PubMed ID: 36880731)
1. Proteolytic regulation of a galectin-3/Lrp1 axis controls osteoclast-mediated bone resorption.
Zhu L; Tang Y; Li XY; Kerk SA; Lyssiotis CA; Sun X; Wang Z; Cho JS; Ma J; Weiss SJ
J Cell Biol; 2023 Apr; 222(4):. PubMed ID: 36880731
[TBL] [Abstract][Full Text] [Related]
2. Open Thy Lattice Osteoclast, Resorb me!
Bakiri L
J Cell Biol; 2023 Apr; 222(4):. PubMed ID: 36928467
[TBL] [Abstract][Full Text] [Related]
3. Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases.
Zhu L; Tang Y; Li XY; Keller ET; Yang J; Cho JS; Feinberg TY; Weiss SJ
Sci Transl Med; 2020 Feb; 12(529):. PubMed ID: 32024800
[TBL] [Abstract][Full Text] [Related]
4. Membrane localization of membrane type 1 matrix metalloproteinase by CD44 regulates the activation of pro-matrix metalloproteinase 9 in osteoclasts.
Chellaiah MA; Ma T
Biomed Res Int; 2013; 2013():302392. PubMed ID: 23984338
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of osteoclast bone resorption activity through osteoprotegerin-induced damage of the sealing zone.
Song R; Gu J; Liu X; Zhu J; Wang Q; Gao Q; Zhang J; Cheng L; Tong X; Qi X; Yuan Y; Liu Z
Int J Mol Med; 2014 Sep; 34(3):856-62. PubMed ID: 25017214
[TBL] [Abstract][Full Text] [Related]
6. The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.
Vinik Y; Shatz-Azoulay H; Vivanti A; Hever N; Levy Y; Karmona R; Brumfeld V; Baraghithy S; Attar-Lamdar M; Boura-Halfon S; Bab I; Zick Y
Elife; 2015 May; 4():e05914. PubMed ID: 25955862
[TBL] [Abstract][Full Text] [Related]
7. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
[TBL] [Abstract][Full Text] [Related]
8. miR-31 controls osteoclast formation and bone resorption by targeting RhoA.
Mizoguchi F; Murakami Y; Saito T; Miyasaka N; Kohsaka H
Arthritis Res Ther; 2013; 15(5):R102. PubMed ID: 24004633
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis.
Simon D; Derer A; Andes FT; Lezuo P; Bozec A; Schett G; Herrmann M; Harre U
Bone; 2017 Dec; 105():35-41. PubMed ID: 28822790
[TBL] [Abstract][Full Text] [Related]
10. Substrate stiffness regulates the differentiation profile and functions of osteoclasts via cytoskeletal arrangement.
Wang Q; Xie J; Zhou C; Lai W
Cell Prolif; 2022 Jan; 55(1):e13172. PubMed ID: 34953003
[TBL] [Abstract][Full Text] [Related]
11. Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes.
Löfvall H; Newbould H; Karsdal MA; Dziegiel MH; Richter J; Henriksen K; Thudium CS
Arthritis Res Ther; 2018 Apr; 20(1):67. PubMed ID: 29636095
[TBL] [Abstract][Full Text] [Related]
12. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX
Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
[TBL] [Abstract][Full Text] [Related]
13. CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss.
Collins FL; Williams JO; Bloom AC; Singh RK; Jordan L; Stone MD; McCabe LR; Wang ECY; Williams AS
Bone; 2017 Apr; 97():94-104. PubMed ID: 28062298
[TBL] [Abstract][Full Text] [Related]
14. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
[TBL] [Abstract][Full Text] [Related]
15. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation.
Duong LT; Rodan GA
Front Biosci; 1998 Aug; 3():d757-68. PubMed ID: 9682033
[TBL] [Abstract][Full Text] [Related]
16. Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.
Kittaka M; Mayahara K; Mukai T; Yoshimoto T; Yoshitaka T; Gorski JP; Ueki Y
J Bone Miner Res; 2018 Jan; 33(1):167-181. PubMed ID: 28914985
[TBL] [Abstract][Full Text] [Related]
17. The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors.
Sato T; Foged NT; Delaissé JM
J Bone Miner Res; 1998 Jan; 13(1):59-66. PubMed ID: 9443791
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-12 (MMP-12) in osteoclasts: new lesson on the involvement of MMPs in bone resorption.
Hou P; Troen T; Ovejero MC; Kirkegaard T; Andersen TL; Byrjalsen I; Ferreras M; Sato T; Shapiro SD; Foged NT; Delaissé JM
Bone; 2004 Jan; 34(1):37-47. PubMed ID: 14751561
[TBL] [Abstract][Full Text] [Related]
19. MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production.
Delgado-Calle J; Hancock B; Likine EF; Sato AY; McAndrews K; Sanudo C; Bruzzaniti A; Riancho JA; Tonra JR; Bellido T
FASEB J; 2018 May; 32(5):2878-2890. PubMed ID: 29401593
[TBL] [Abstract][Full Text] [Related]
20. A Zeb1/MtCK1 metabolic axis controls osteoclast activation and skeletal remodeling.
Zhu L; Tang Y; Li XY; Kerk SA; Lyssiotis CA; Feng W; Sun X; Hespe GE; Wang Z; Stemmler MP; Brabletz S; Brabletz T; Keller ET; Ma J; Cho JS; Yang J; Weiss SJ
EMBO J; 2023 Apr; 42(7):e111148. PubMed ID: 36843552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
